FindTrial
Sign In

The protective effect and mechanism of prenatal corticosteroids alone or combined with magnesium sulfate exposure on hearing in premature infants

The protective effect and mechanism of prenatal corticosteroids alone or combined with magnesium sulfate exposure on hearing in premature infants

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300071423
Enrollment
Unknown
Registered
2023-05-15
Start date
2023-06-01
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hear

Interventions

Prenatal corticosteroid therapy group (Different doses of prenatal corticosteroid hormone therapy):None

Sponsors

West China Second Hospital,Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 55 Years

Inclusion criteria

Inclusion criteria: Premature infants with gestational age < 35 weeks.

Exclusion criteria

Exclusion criteria: 1 Congenital brain / neural tube defects ; 2 diagnosed as congenital infection ; 3 ear fistula ; 4 chromosome abnormality ; 5 maxillofacial deformity ; 6 family history of deafness ; 7 Use deafness-causing antibiotics.

Design outcomes

Primary

MeasureTime frame
hearing loss;—

Countries

china

Contacts

Public ContactHuangyan

West China Second Hospital,Sichuan University

yanranteam@163.com+86 181 8060 9179

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026